We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+3.49%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$36.8B
AUM Growth
+$1.59B
(+4.5%)
Cap. Flow
+$616M
Cap. Flow
% of AUM
1.67%
Top 10 Holdings %
Top 10 Hldgs %
30.2%
Holding
1,210
New
158
Increased
302
Reduced
461
Closed
201
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$101M |
| 2 |
ARMH
ARM HOLDINGS PLC ADS
ARMH
|
+$88.4M |
| 3 |
Qualcomm
QCOM
|
+$75.3M |
| 4 |
Coca-Cola
KO
|
+$71.4M |
| 5 |
Newell Brands
NWL
|
+$70.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$182M |
| 2 |
JAH
JARDEN CORPORATION
JAH
|
+$86M |
| 3 |
Prudential Financial
PRU
|
+$56.8M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$53.2M |
| 5 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$37.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.56% |
| 2 | Consumer Discretionary | 12.26% |
| 3 | Healthcare | 12.15% |
| 4 | Financials | 11.81% |
| 5 | Communication Services | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Neurocrine Biosciences
NBIX
$16.7B
| $7K | ﹤0.01% |
163
+53
| +48% | +$2.44K |
|
|
ACH
777
Accendra Health
ACH
$238M
| $7K | ﹤0.01% |
186
-85
| -31% | -$3.19K |
|
778
Phibro Animal Health
PAHC
$1.41B
| $7K | ﹤0.01% |
361
-312
| -46% | -$6.51K |
|
779
Repligen
RGEN
$9.22B
| $7K | ﹤0.01% |
241
-85
| -26% | -$2.17K |
|
780
Southwest Gas
SWX
$6.68B
| $7K | ﹤0.01% |
86
-195
| -69% | -$13.5K |
|
781
AT&T
T
$164B
| $7K | ﹤0.01% |
204
-458,758
| -100% | -$13.7M |
|
782
TriCo Bancshares
TCBK
$1.85B
| $7K | ﹤0.01% |
242
-96
| -28% | -$2.59K |
|
783
Universal Insurance Holdings
UVE
$1.24B
| $7K | ﹤0.01% |
386
-609
| -61% | -$11K |
|
|
MGLN
784
DELISTED
Magellan Health Services, Inc.
MGLN
| $7K | ﹤0.01% |
102
-97
| -49% | -$6.53K |
|
|
CSC
785
DELISTED
Computer Sciences
CSC
| $7K | ﹤0.01% |
147
-191
| -57% | -$7.72K |
|
786
Archer Daniels Midland
ADM
$36.8B
| $6K | ﹤0.01% |
143
-303
| -68% | -$12.1K |
|
787
American Financial Group
AFG
$12.1B
| $6K | ﹤0.01% |
75
-93
| -55% | -$6.59K |
|
788
ANI Pharmaceuticals
ANIP
$1.77B
| $6K | ﹤0.01% |
103
-24
| -19% | -$1.17K |
|
789
Arrow Electronics
ARW
$10.3B
| $6K | ﹤0.01% |
+104
| New | +$6.6K |
|
790
Avnet
AVT
$7.87B
| $6K | ﹤0.01% |
+147
| New | +$6.13K |
|
791
Conagra Brands
CAG
$7.23B
| $6K | ﹤0.01% |
+159
| New | +$5.67K |
|
792
Chemed
CHE
$7.16B
| $6K | ﹤0.01% |
45
-71
| -61% | -$9.42K |
|
793
Delta Air Lines
DAL
$60.3B
| $6K | ﹤0.01% |
166
-220
| -57% | -$9.35K |
|
|
DMC
794
Del Monte Corp
DMC
$1.45B
| $6K | ﹤0.01% |
104
+35
| +51% | +$1.71K |
|
795
Flowers Foods
FLO
$1.58B
| $6K | ﹤0.01% |
303
-19
| -6% | -$354 |
|
796
GameStop
GME
$8.58B
| $6K | ﹤0.01% |
852
| – | – |
|
797
Global Payments
GPN
$22.5B
| $6K | ﹤0.01% |
81
-67
| -45% | -$4.95K |
|
798
Ingredion
INGR
$6.58B
| $6K | ﹤0.01% |
50
-163
| -77% | -$19K |
|
799
JetBlue
JBLU
$2.3B
| $6K | ﹤0.01% |
343
-421
| -55% | -$7.82K |
|
|
JNPR
800
DELISTED
Juniper Networks
JNPR
| $6K | ﹤0.01% |
271
-27,213
| -99% | -$633K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2016 Portfolio in Review
As of Q2 2016, Loomis, Sayles & Company held 1,210 positions worth $36.8B, up 4.5% from $35.2B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Loomis, Sayles & Company's Q2 2016 filing shows 158 new, 302 increased, 461 reduced and 201 closed positions. Its largest new stake was S&P Global: 444,469 shares worth $47.7M. The largest sale was Lowe's Companies, an estimated $182M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Loomis, Sayles & Company's largest Q2 2016 buy was S&P Global: 444,469 shares worth $47.7M.
- Loomis, Sayles & Company added most to Cerner Corp in Q2 2016, an estimated $101M increase.
- Loomis, Sayles & Company's biggest Q2 2016 reduction was Lowe's Companies, cutting an estimated $182M.
- Loomis, Sayles & Company fully exited JARDEN CORPORATION in Q2 2016, selling an estimated $86M.
- Loomis, Sayles & Company's ten largest holdings make up 30% of its $36.8B portfolio in Q2 2016.
- Loomis, Sayles & Company opened 158 new positions and closed 201 in Q2 2016.
- Loomis, Sayles & Company's portfolio value rose 4.5% quarter-over-quarter to $36.8B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2016, filed 12 Aug 2016.